Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rohit Kulkarni

Showing results (31-40 of 34) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null respondersEdward J Gane, Régine Rouzier, Alicja Wiercinska-Drapalo, et al.
Shoulder & Elbow|August 28, 2018
The Provision of Primary and Revision Elbow Replacement Surgery in the NHSStuart Hay, Rohit Kulkarni, Adam Watts, et al.
Journal of Hepatology|September 21, 2014
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirinJordan J Feld, Ira M Jacobson, Donald M Jensen, et al.
Pageof 4

Showing results (31-40 of 34) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 34 results.
Gastroenterology|January 18, 2012
Effect of IL28B genotype on early viral kinetics during interferon-free treatment of patients with chronic hepatitis CTom W Chu, Rohit Kulkarni, Edward J Gane, et al.
Antimicrobial Agents and Chemotherapy|December 4, 2013
Efficacy and safety of danoprevir-ritonavir plus peginterferon alfa-2a-ribavirin in hepatitis C virus genotype 1 prior null respondersEdward J Gane, Régine Rouzier, Alicja Wiercinska-Drapalo, et al.
Shoulder & Elbow|August 28, 2018
The Provision of Primary and Revision Elbow Replacement Surgery in the NHSStuart Hay, Rohit Kulkarni, Adam Watts, et al.
Journal of Hepatology|September 21, 2014
Randomized study of danoprevir/ritonavir-based therapy for HCV genotype 1 patients with prior partial or null responses to peginterferon/ribavirinJordan J Feld, Ira M Jacobson, Donald M Jensen, et al.
Pageof 4